Cosmos Health Inc. is a diversified, vertically integrated global healthcare company. The Company owns a portfolio of proprietary pharmaceutical and nutraceutical brands, including Sky Premium Life, Mediterranation, bio-bebe, C-Sept and C-Scrub. Through its subsidiary Cana Laboratories S.A., it manufactures pharmaceuticals, food supplements, cosmetics, biocides, and medical devices within the European Union. It also distributes a broad line of pharmaceuticals and parapharmaceuticals, including branded generics and over-the-counter (OTC) medications, to retail pharmacies and wholesale distributors through its subsidiaries in Greece and the United Kingdom. It also has research and development (R&D) partnerships targeting health disorders such as obesity, diabetes, and cancer, enhanced by artificial intelligence drug repurposing technologies, and focuses on the R&D of patented nutraceuticals, specialized root extracts, proprietary complex generics, and OTC products.
äŒæ¥ã³ãŒãCOSM
äŒç€ŸåCosmos Health Inc
äžå Žæ¥May 19, 2010
æé«çµå¶è²¬ä»»è
ãCEOãSiokas (Grigorios)
åŸæ¥å¡æ°149
蚌åžçš®é¡Ordinary Share
æ±ºç®ææ«May 19
æ¬ç€Ÿæåšå°5 Agiou Georgiou, Pilea
éœåžTHESSALONIKI
蚌åžååŒæNASDAQ OMX - NASDAQ BASIC
åœGreece
éµäŸ¿çªå·554 38
é»è©±çªå·303125363102
ãŠã§ããµã€ãhttps://www.cosmosholdingsinc.com/
äŒæ¥ã³ãŒãCOSM
äžå Žæ¥May 19, 2010
æé«çµå¶è²¬ä»»è
ãCEOãSiokas (Grigorios)
éå»5幎éã®é
åœéç·æ¯æé¡ã¯
0.00
ç±³ãã«ã§ããã

ããŒã¿ãªã